For instance, it has been shown that in most BM samples from AML patients, the important SAC regulator BubR1 is downregulated, whereas other SAC-involved genes such as budding uninhibited by benzimidazoles 1 (Bub1) and Bub3 were not mis-regulated [38]. The gene discussed is ADCY10; the disease is acute myeloid leukemia.